Multi-scale modeling of folic acid-functionalized TiO$_{2}$ nanoparticles for active targeting of tumor cells
Edoardo Donadoni, Paulo Siani, Giulia Frigerio, Cristiana Di Valentin

TL;DR
This study uses computational modeling to compare direct and PEG-spaced folic acid attachment on TiO2 nanoparticles, revealing how these configurations affect stability and targeting ligand exposure for tumor cell targeting.
Contribution
It combines quantum mechanics and molecular dynamics to optimize and analyze folic acid functionalization on TiO2 nanoparticles, providing insights into the effects of PEG spacers on targeting efficiency.
Findings
FA-functionalized TiO2 NPs are chemically stable up to 500 K
PEG spacers influence FA exposure and intermolecular interactions
Optimal FA density depends on anchoring mode and spacer presence
Abstract
Strategies based on the active targeting of tumor cells are emerging as smart and efficient nanomedical procedures. Folic acid (FA) is a vitamin and a well-established tumor targeting agent because of its strong affinity for the folate receptor (FR), which is an overexpressed protein on the cell membranes of the tumor cells. FA can be successfully anchored to several nanocarriers, including inorganic nanoparticles (NPs) based on transition metal oxides. Among them, TiO is extremely interesting because of its excellent photoabsorption and photocatalytic properties, which can be exploited in photodynamic therapy. However, it is not yet clear in which respects direct anchoring of FA to the NP or the use of spacers, based on polyethylene glycol (PEG) chains, are different and whether one approach is better than the other. In this work, we combine Quantum Mechanics (QM) and Classical…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
